Most not too long ago, it's been recognized that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to the big selection of endogenous opioids. In contrast to most opioid receptors, this receptor functions for a scavenger and won't act